rs9926309

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001009944.3(PKD1):​c.8913T>C​(p.Ala2971Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00547 in 1,594,920 control chromosomes in the GnomAD database, including 450 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.032 ( 241 hom., cov: 32)
Exomes 𝑓: 0.0029 ( 209 hom. )

Consequence

PKD1
NM_001009944.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -1.96

Publications

3 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • polycystic kidney disease 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Caroli disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.036).
BP6
Variant 16-2102849-A-G is Benign according to our data. Variant chr16-2102849-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257031.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.96 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.108 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001009944.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PKD1
NM_001009944.3
MANE Select
c.8913T>Cp.Ala2971Ala
synonymous
Exon 24 of 46NP_001009944.3P98161-1
PKD1
NM_000296.4
c.8913T>Cp.Ala2971Ala
synonymous
Exon 24 of 46NP_000287.4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PKD1
ENST00000262304.9
TSL:1 MANE Select
c.8913T>Cp.Ala2971Ala
synonymous
Exon 24 of 46ENSP00000262304.4P98161-1
PKD1
ENST00000423118.5
TSL:1
c.8913T>Cp.Ala2971Ala
synonymous
Exon 24 of 46ENSP00000399501.1P98161-3
PKD1
ENST00000480227.5
TSL:1
n.650T>C
non_coding_transcript_exon
Exon 2 of 8

Frequencies

GnomAD3 genomes
AF:
0.0319
AC:
4444
AN:
139172
Hom.:
242
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.111
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0111
Gnomad ASJ
AF:
0.000932
Gnomad EAS
AF:
0.00107
Gnomad SAS
AF:
0.000236
Gnomad FIN
AF:
0.000101
Gnomad MID
AF:
0.00680
Gnomad NFE
AF:
0.000812
Gnomad OTH
AF:
0.0299
GnomAD2 exomes
AF:
0.00775
AC:
1928
AN:
248664
AF XY:
0.00559
show subpopulations
Gnomad AFR exome
AF:
0.102
Gnomad AMR exome
AF:
0.00660
Gnomad ASJ exome
AF:
0.000902
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0000472
Gnomad NFE exome
AF:
0.000420
Gnomad OTH exome
AF:
0.00279
GnomAD4 exome
AF:
0.00293
AC:
4262
AN:
1455626
Hom.:
209
Cov.:
34
AF XY:
0.00248
AC XY:
1798
AN XY:
724176
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0964
AC:
3147
AN:
32630
American (AMR)
AF:
0.00738
AC:
328
AN:
44456
Ashkenazi Jewish (ASJ)
AF:
0.000804
AC:
21
AN:
26114
East Asian (EAS)
AF:
0.000227
AC:
9
AN:
39674
South Asian (SAS)
AF:
0.000244
AC:
21
AN:
86010
European-Finnish (FIN)
AF:
0.0000387
AC:
2
AN:
51724
Middle Eastern (MID)
AF:
0.00484
AC:
20
AN:
4134
European-Non Finnish (NFE)
AF:
0.000260
AC:
289
AN:
1110828
Other (OTH)
AF:
0.00708
AC:
425
AN:
60056
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.364
Heterozygous variant carriers
0
158
316
474
632
790
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0320
AC:
4458
AN:
139294
Hom.:
241
Cov.:
32
AF XY:
0.0308
AC XY:
2089
AN XY:
67908
show subpopulations
African (AFR)
AF:
0.111
AC:
4187
AN:
37680
American (AMR)
AF:
0.0111
AC:
153
AN:
13802
Ashkenazi Jewish (ASJ)
AF:
0.000932
AC:
3
AN:
3220
East Asian (EAS)
AF:
0.00108
AC:
5
AN:
4648
South Asian (SAS)
AF:
0.000237
AC:
1
AN:
4226
European-Finnish (FIN)
AF:
0.000101
AC:
1
AN:
9930
Middle Eastern (MID)
AF:
0.00730
AC:
2
AN:
274
European-Non Finnish (NFE)
AF:
0.000812
AC:
51
AN:
62798
Other (OTH)
AF:
0.0294
AC:
55
AN:
1868
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
173
347
520
694
867
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00818
Hom.:
15
Bravo
AF:
0.0336
EpiCase
AF:
0.000654
EpiControl
AF:
0.000593

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
3
not provided (3)
-
-
1
Polycystic kidney disease (1)
-
-
1
Polycystic kidney disease, adult type (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.071
DANN
Benign
0.41
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9926309; hg19: chr16-2152850; API